Gross Margin

61.4%
Current
Declining
by 0.1%
vs 3-y average of 61.6%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
61.4%
=
Gross Profit
$494m
/
Revenue
$804.3m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
61.4%
=
Gross Profit
$494m
/
Revenue
$804.3m

Peer Comparison

Country Company Market Cap Gross
Margin
IS
Ossur hf
CSE:OSSR
11.3B DKK
Loading...
US
Abbott Laboratories
NYSE:ABT
188.2B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
168.4B USD
Loading...
US
Stryker Corp
NYSE:SYK
130B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
112B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
102.5B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
43.9B EUR
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.6B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
45.8B USD
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
33.7B USD
Loading...

Market Distribution

Higher than 80% of companies in Iceland
Percentile
80th
Based on 27 companies
80th percentile
61.4%
Low
0.1% — 0.4%
Typical Range
0.4% — 41%
High
41% — 86.6%
Distribution Statistics
Iceland
Min 0.1%
30th Percentile 0.4%
Median 9.5%
70th Percentile 41%
Max 86.6%

Ossur hf
Glance View

Market Cap
1.9B USD
Industry
Health Care

Össur hf. is an Icelandic company that stands as a quiet marvel in the realm of orthopedic innovation, specializing in the development of non-invasive equipment designed to enhance human mobility. Born out of a small prosthetics shop in Reykjavik in 1971, the company has grown into a global leader in orthopedic solutions. At its core, Össur's operations revolve around the invention and commercialization of cutting-edge prosthetics, braces, and supports aimed at improving the quality of life for people who face limb challenges due to injuries, disabilities, or age-related conditions. The company's ethos of "Life Without Limitations" guides its pursuit to blend medical technology and engineering in a way that restores human dignity and functionality, manifesting a unique synergy between advanced robotics and biology. Commercially, Össur thrives by leveraging its commitment to research and development, channeling substantial investment into creating high-demand products characterized by reliability, adaptability, and innovation. Revenue streams primarily flow from the sale of prosthetic limbs and associated components, together with orthopedic support products that are distributed both directly and through a network of wholesalers and medical professionals worldwide. By maintaining a diversified product line and focusing on customer-centric customization, Össur meets a significant demand within healthcare systems, insurance providers, and direct consumer markets. The company's ability to translate its scientific prowess into marketable and life-enhancing solutions has cemented its reputation as a key player in the med-tech industry, aligning financial success with a meaningful social mission.

OSSUY Intrinsic Value
Not Available
O
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
61.4%
=
Gross Profit
$494m
/
Revenue
$804.3m
What is Ossur hf's current Gross Margin?

The current Gross Margin for Ossur hf is 61.4%, which is below its 3-year median of 61.6%.

How has Gross Margin changed over time?

Over the last 3 years, Ossur hf’s Gross Margin has decreased from 62.5% to 61.4%. During this period, it reached a low of 61.2% on Dec 31, 2022 and a high of 63.6% on Jun 30, 2021.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett